TY - JOUR AU - Hammer, Hilde Berner AU - Fagerhol, Magne K. AU - Wien, Tale Norbye AU - Kvien, Tore K. PY - 2011 DA - 2011/10/26 TI - The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab JO - Arthritis Research & Therapy SP - R178 VL - 13 IS - 5 AB - Calprotectin (MRP8/MRP14, S100A8/A9) is associated with disease activity in patients with rheumatoid arthritis (RA). Ultrasonography (US) is a reliable method for evaluation of synovitis (B-mode (BM) and power Doppler (PD)). The present objectives were to explore in RA patients the associations between calprotectin and a comprehensive US examination, as well as the responsiveness of calprotectin compared to other inflammatory markers during anti-TNF treatment. SN - 1478-6354 UR - https://doi.org/10.1186/ar3503 DO - 10.1186/ar3503 ID - Hammer2011 ER -